Latest Headlines

  1. Watchmaker Genomics Expands Molecular Diagnostics Tools Portfolio With Launch Of Stellar RT-qPCR And qPCR Kits 5/14/2026

    Watchmaker Genomics, an innovator in high-performance tools for molecular diagnostic (MDx) assay developers, today announced the expansion of its MDx tools portfolio with the launch of Stellar RT-qPCR and qPCR Kits.

  2. Mayo Clinic And Stanford Researchers Develop First Blood Test To Map Tumor 'Neighborhoods,' Improving Prediction Of Therapy Response 5/6/2026

    Mayo Clinic and Stanford Medicine researchers have developed the first blood test to map the complex ecosystem surrounding cancer cells, offering a more accurate way to predict which patients will benefit from immunotherapy.

  3. Lucent Diagnostics Announces Collaboration With Tempus To Integrate Blood-Based Alzheimer's Biomarker Testing Into Clinical Workflows 5/6/2026

    Lucent Diagnostics, a brand of Quanterix Corporation, today announced a collaboration with Tempus AI Inc, a technology company leading the adoption of AI to advance precision medicine, to broaden access to a novel blood-based biomarker panel designed to improve detection accuracy for Alzheimer’s disease.

  4. MLM Medical Labs Launches Electronic Requisition Solution To Reduce Errors, Simplify Workflows And Accelerate Timelines 5/6/2026

    MLM Medical Labs (MLM), a leading central and specialty laboratory supporting global clinical trials, today announced the launch of its Electronic Requisition (e-Requisition) solution, designed to address one of the most persistent challenges in clinical trials: incomplete, inaccurate, and delayed sample data originating at the clinical trial site.

  5. PathAI And A.C.Camargo Cancer Center Announce Cooperation To Expand Digital Pathology With AI In Brazil Via SUS 5/5/2026

    PathAI, a global leader in AI-powered digital pathology solutions, and A.C.Camargo Cancer Center, a national benchmark in oncological treatment, education, and research, are joining forces strategically to support the adoption of digital and AI-enabled pathology across Brazil.

  6. arcoris bio Launches ImmunoMUSE, Enabling Flexible, High-Sensitivity Multiplex Immunofluorescence With User-Defined Antibodies 5/5/2026

    arcoris bio, a Swiss life science research tools and in vitro diagnostics company, today announced the launch of its immunoMUSE kits, based on its breakthrough MUSE biomarker detection platform.

  7. CS Analytical Announces Major Laboratory Expansion 5/4/2026

    CS Analytical Laboratory, the world's only cGMP, FDA-registered and inspected contract laboratory exclusively designed and dedicated to package and container testing for the pharmaceutical, biotechnology, and medical device industries is excited to announce that it has just finalized plans to double the current laboratory space for its Clifton, New Jersey facility.

  8. BillionToOne Launches Unity Confirm™: A Category-Defining Test That Bridges The Gap Between Screening And Invasive Diagnostics 5/1/2026

    For more than two decades, the ultimate quest for scientists and clinicians studying prenatal genetics was the capture of an intact fetal cell non-invasively so that its fetal DNA could be directly analyzed.

  9. Lab Thread Introduces Unified Lab Software Platform To Streamline Biological Research 4/30/2026

    Lab Thread Ltd, a UK-based life science software company, today announced the worldwide commercial release of its Unified Lab Software Platform.

  10. Guardant Health Announces Multi-Year Strategic Collaboration With Nuvalent To Develop Companion Diagnostics And Support Potential Commercialization Of Targeted Cancer Therapies Using The Guardant Infinity Platform 4/30/2026

    Guardant Health, Inc., a leading precision oncology company, today announced a multi-year strategic collaboration with Nuvalent, Inc. a clinical-stage biopharmaceutical company focused on creating precisely targeted therapies for clinically proven kinase targets in cancer, to support the development and potential commercialization of Nuvalent’s oncology pipeline using the tissue and liquid offerings of the Guardant Infinity platform.